Aclasta is a new standard of the efficiency of antiresorptive therapy: One-ayear infusion by A M Mkrtumyan, L V Nedosugova, E V Biryukova, A M Mkrtumyan, L V Nedosugova, Ye V Biryukova

Get full text

Some mechanisms of inflammation development in type 2 diabetes mellitus by L. A. Bochkareva, L. V. Nedosugova, N. A. Petunina, M. Е. Теlnova, E. V. Goncharova

Get full text

The role of pioglitazone in the fight against insulin resistance, atherosclerosis, cardiovascular disease, and non-alcoholic fatty liver disease by N. A. Petunina, E. V. Goncharova, I. A. Kuzina, L. V. Nedosugova, N. S. Martirosyan, M. Е. Теlnova

Get full text

SIGNIFICANCE OF M1 AND M2 POLARIZATION OF MONOCYTES-MACROPHAGES IN THE BLOOD FOR ATHEROSCLEROSIS RISK ASSESSMENT IN TYPE 2 DIABETES COMPARING WITH CORONARY HEART DISEASE by К. О. Galstyan, L. V. Nedosugova, N. G. Nikiforov, К. I. Kolmychkova, Т. V. Kirichenko, I. A. Sobenin

Get full text

Spontaneous and induced secretion of the pro-inflammatory and anti-inflammatory cytokines in patients with type 2 diabetes mellitus and diabetic foot syndrome by E. V. Shikh, N. A. Petunina, L. V. Nedosugova, K. O. Galstyan, K. I. Kolmychkova, A. A. Makhova, Galin I. Gorodetskaya

Get full text